Bejelentkezés Regisztrálj ingyen

NeuroVive Pharmaceutical AB Bruttó árrés

Mi az NeuroVive Pharmaceutical AB Bruttó árrés?

A Bruttó árrés az NeuroVive Pharmaceutical AB - -68,572.19%

Mi a Bruttó árrés meghatározása?



A bruttó árrés az árbevétel és az eladott áruk költségének különbsége, osztva bevételekkel, és százalékban kifejezve.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Bruttó árrés a Miscellaneous szektor a LSE-on cégekben a NeuroVive Pharmaceutical AB -hoz képest

Mit csinál NeuroVive Pharmaceutical AB?

Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

bruttó árrés -hoz hasonló cégek NeuroVive Pharmaceutical AB